Cargando…

Thyroid Remnant Estimation by Diagnostic Dose (131) I Scintigraphy or (99m) T c O (4) (−) Scintigraphy after Thyroidectomy: A Comparison with Therapeutic Dose (131) I Imaging

In this clinical study, we have compared routine diagnostic dose (131)I scan and (99m)TcO(4) (−) thyroid scintigraphy with therapeutic dose (131)I imaging for accurate thyroid remnant estimation after total thyroidectomy. We conducted a retrospective review of the patients undergoing total thyroidec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Guanghui, Li, Na, Li, Xuena, Chen, Song, Du, Bulin, Li, Yaming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806647/ https://www.ncbi.nlm.nih.gov/pubmed/27034938 http://dx.doi.org/10.1155/2016/4763824

Ejemplares similares

I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer
por: Lin, Rong, et al.
Publicado: (2015)

A Quantitative Evaluation of Hepatic Uptake on I-131 Whole-Body Scintigraphy for Postablative Therapy of Thyroid Carcinoma
por: Nakayama, Michihiro, et al.
Publicado: (2015)

Site-based performance of (131)I-MIBG imaging and (99m)Tc-HYNIC-TOC scintigraphy in the detection of nonmetastatic extra-adrenal paraganglioma
por: Hou, Guozhu, et al.
Publicado: (2021)

Does the use of recombinant TSH in preparation for I-131 scintigraphy scan affect hearing function?
por: Doğan, Mehtap, et al.
Publicado: (2018)

I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence
por: Shengguang, Yan, et al.
Publicado: (2016)

Incremental diagnostic value of [(18)F]tetrafluoroborate PET-CT compared to [(131)I]iodine scintigraphy in recurrent differentiated thyroid cancer
por: Dittmann, Matthias, et al.
Publicado: (2020)

Recurrence Incidence in Differentiated Thyroid Cancers and the Importance of Diagnostic Iodine-131 Scintigraphy in Clinical Follow-up
por: Hatipoğlu, Filiz, et al.
Publicado: (2016)

Ectopic Cortisol-producing Adrenocortical Adenoma Detected by 131I-6β-iodomethyl-norcholesterol Scintigraphy
por: Sato, Seisuke, et al.
Publicado: (2020)

Diagnostic Value of I-131 NP-59 SPECT/CT Scintigraphy in Patients with Subclinical or Atypical Features of Primary Aldosteronism
por: Chen, Yi-Chun, et al.
Publicado: (2011)

Diagnostic Use of Post-therapy (131)I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma
por: Wakabayashi, Hiroshi, et al.
Publicado: (2020)

Unusual iodine‐131 postablation whole‐body scintigraphy patterns in patients after robot‐assisted/endoscopic thyroidectomy: Case series
por: Kim, Mi Ra, et al.
Publicado: (2020)

I-131 mIBG Scintigraphy Curie Versus SIOPEN Scoring: Prognostic Value in Stage 4 Neuroblastoma
por: Riaz, Saima, et al.
Publicado: (2018)

Thyroid dose assessments due to inhalation of (131)I for nuclear medicine workers
por: Liu, Gang, et al.
Publicado: (2022)

Quantitative Scintigraphy Evaluated the Relationship between 131I Therapy and Salivary Glands Function in DTC Patients: A Retrospective Analysis
por: Lv, Xiaolan, et al.
Publicado: (2022)

Adrenal (131)I-6β-iodomethylnorcholesterol scintigraphy in choosing the side for adrenalectomy in bilateral adrenal tumors with subclinical hypercortisolemia
por: Papierska, Lucyna, et al.
Publicado: (2015)

The clinical significance of remnant thyroid tissue in thyroidectomized differentiated thyroid cancer patients on (131)I-SPECT/CT
por: Wang, Feng, et al.
Publicado: (2021)

Preablation Stimulated Thyroglobulin/TSH Ratio as a Predictor of Successful I(131)Remnant Ablation in Patients with Differentiated Thyroid Cancer following Total Thyroidectomy
por: Zubair Hussain, Syed, et al.
Publicado: (2014)

A Neck-Thyroid Phantom with Small Sizes of Thyroid Remnants for Postsurgical I-123 and I-131 SPECT/CT Imaging
por: Michael, Konstantinos, et al.
Publicado: (2023)

Complete remission of metastatic pheochromocytoma in (123)I-metaiodobenzylguanidine scintigraphy after a single session of (131)I-metaiodobenzylguanidine therapy: a case report
por: Sugino, Teruaki, et al.
Publicado: (2017)

I-131 Dose Response for Incident Thyroid Cancers in Ukraine Related to the Chornobyl Accident
por: Brenner, Alina V., et al.
Publicado: (2011)

MON-559 Inappropriate Dosing of I-131 in Non-Metastatic Differentiated Thyroid Cancer
por: Alzenaidi, Ahlam, et al.
Publicado: (2019)

Efficacy and Affecting Factors of (131)I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma
por: Wang, Chen, et al.
Publicado: (2018)

The Role of Tc-99m DTPA Renal Dynamic Scintigraphy in Retroperitoneal Liposarcoma
por: Wang, Ying, et al.
Publicado: (2020)

Rate of thyroglossal duct remnant visualization after total thyroidectomy for differentiated thyroid carcinoma and its impact on clinical outcome of radioactive iodine (I-131) ablation
por: Mohamed Sayed, Mohamed Hosny, et al.
Publicado: (2015)

Diagnostic Accuracy of Adrenal Iodine-131 6-Beta-Iodomethyl-19-Norcholesterol Scintigraphy for the Subtyping of Primary Aldosteronism
por: Araujo-Castro, Marta, et al.
Publicado: (2023)

The Molecular Effect of Diagnostic Absorbed Doses from (131)I on Papillary Thyroid Cancer Cells In Vitro
por: Stasiołek, Mariusz, et al.
Publicado: (2017)

Strong Neck Accumulation of (131)I Is a Predictor of Incomplete Low-Dose Radioiodine Remnant Ablation Using Recombinant Human Thyroid-Stimulating Hormone
por: Enomoto, Keisuke, et al.
Publicado: (2015)

Unusual case of hepatic metastasis in follicular thyroid carcinoma detected using I-131 whole body scintigraphy and single-photon emission computerized tomography/computerized tomography
por: Kamaleshwaran, Koramadai Karuppusamy, et al.
Publicado: (2015)

The Effect of Diagnostic Absorbed Doses from (131)I on Human Thyrocytes in Vitro
por: Adamczewski, Zbigniew, et al.
Publicado: (2015)

Values of (99m)Tc-methoxyisobutylisonitrile imaging after first-time large-dose (131)I therapy in treating differentiated thyroid cancer
por: Pan, Xiaomei, et al.
Publicado: (2016)

Empiric Therapy with Low-Dose I-131 in Differentiated Cancer Thyroid: What is the Magic Number?
por: Shinto, Ajit S., et al.
Publicado: (2013)

Recurrent malignant pheochromocytoma with unusual omental metastasis: (68)Ga-DOTANOC PET/CT and (131)I-MIBG SPECT/CT scintigraphy findings
por: Arora, Saurabh, et al.
Publicado: (2014)

A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance
por: Howard, Brandon A, et al.
Publicado: (2017)

Unusual False Positive Radioiodine Uptake on (131)I Whole Body Scintigraphy in Three Unrelated Organs with Different Pathologies in Patients of Differentiated Thyroid Carcinoma: A Case Series
por: Ranade, Rohit, et al.
Publicado: (2016)

Role of single photon emission computed tomography/computed tomography in diagnostic iodine-131 scintigraphy before initial radioiodine ablation in differentiated thyroid cancer
por: Agrawal, Kanhaiyalal, et al.
Publicado: (2015)

Induction of Leukaemia by (131)I Treatment of Thyroid Carcinoma
por: Brincker, H., et al.
Publicado: (1973)

Malignant Struma Ovarii: Good Response after Thyroidectomy and (131)I Ablation Therapy
por: Janszen, Erica W.M., et al.
Publicado: (2008)

Comparison between planar and single-photon computed tomography images for radiation intensity quantification in iodine-131 scintigraphy
por: Iizuka, Yusuke, et al.
Publicado: (2021)

The influence of thionamides on intra-thyroidal uptake of (131)I during radioiodine-131 treatment of Graves’ disease
por: Happel, Christian, et al.
Publicado: (2023)

Optimizing reconstruction parameters for quantitative (124)I-PET in the presence of therapeutic doses of (131)I
por: Fanchon, Louise M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qo3hhsioh2fbkr63lkhtijcoll